Search
Overactive Bladder Clinical Trials
A listing of 24 Overactive Bladder clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 24
There are currently 24 active clinical trials seeking participants for Overactive Bladder research studies. The states with the highest number of trials for Overactive Bladder participants are Florida, California, Texas and New York.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Type 2 Diabetes Clinical Trial
Recruiting
Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.
Conditions:
Type 2 Diabetes
Diabetes Mellitus Type 2 in Obese
Diabetes Type Two
Type 2 Diabetes Mellitus
Diabete Type 2
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Recruiting
The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed... Read More
Gender:
ALL
Ages:
Between 8 years and 18 years
Trial Updated:
05/02/2025
Locations: Duke University Hospital, Durham, North Carolina
Conditions: Overactive Bladder, Overactive Bladder Syndrome, Overactive Detrusor
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
03/28/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +5 locations
Conditions: Overactive Bladder, Urinary Urgency Incontinence, Benign Prostatic Hyperplasia, Prostate Cancer, Prostatectomy
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Recruiting
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
03/26/2025
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Bladder Dysfunction, Overactive Bladder, BPH With Urinary Obstruction
Effect of Extended Release Torsemide in Patients with Congestive Heart Failure and Overactive Bladder
Recruiting
This research study is being done to compare the effectiveness two drugs: an extended release torsemide (ERT) versus generic immediate release Torsemide (IRT) in reducing the worsening of symptoms of Overactive Bladder (OAB i.e., frequency, urgency, or urgency incontinence) in patients with chronic congestive heart failure (CHF).
This study will include CHF patients who experience worsening OAB) symptoms with use of a loop diuretic. The total duration of the study is about eight weeks with a to... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
03/25/2025
Locations: Cardiometabolic Research Unit, Dallas, Texas
Conditions: Heart Failure, Overactive Bladder, Incontinence
Urinary Microbiome Changes Following Administration of 500 Mg of NDS-446 in Women with Dry OAB At 12 Weeks
Recruiting
The purpose of this study is to learn about how the use of 500 mg of dried cranberry powder extract (NDS-446) changes the bacteria that normal reside in the bladder of women who don't have urinary leakage problems but do have problems with urinary urgency and frequency.
Gender:
FEMALE
Ages:
Between 18 years and 99 years
Trial Updated:
03/03/2025
Locations: Loyola Medical Center, Maywood, Illinois
Conditions: Overactive Bladder
Bladder Botox UTI Antibiotic Prophylaxis
Recruiting
Overactive bladder (OAB) is a common condition with a prevalence of 17% in the general population that significantly affects quality of life. Intradetrusor onabotulinumtoxinA injections are an advanced therapy for OAB as well as interstitial cystitis/bladder pain syndrome (IC/BPS). The most common adverse event following intradetrusor injection of onabotulinumtoxinA in urinary tract infection (UTI), which occurs in 8.6-48.1% of patients. To prevent UTIs, patients are given a course of antibiotic... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/14/2025
Locations: Walter Reed National Military Medical Center, Bethesda, Maryland
Conditions: Overactive Bladder, Bladder Pain Syndrome
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Recruiting
Neurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bladder, is the most common urinary complaint in multiple sclerosis (MS). Current management options for NOAB in MS have limited efficacy and considerable adverse effects, which underscores the significance of this study and highlights the need for better, less invasive therapies. This novel study investigates brain therapeutic targets that... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
02/12/2025
Locations: Houston Methodist Hospital, Houston, Texas
rTMS in Overactive Bladder
Recruiting
Overactive bladder (OAB) imposes a significant quality of life, mental health, and economic burdens. OAB with or without Urgency incontinence is associated with depression, sexual dysfunction, and limitation of social interactions and physical activities, which significantly affects quality of life.
Non-invasive neuromodulation with repetitive transcranial magnetic stimulation (rTMS) can be used in research settings to investigate responses to focal regional brain activation. In the clinical se... Read More
Gender:
ALL
Ages:
Between 40 years and 80 years
Trial Updated:
02/11/2025
Locations: Houston Methodist Hospital, Houston, Texas
Conditions: Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence, Urgency-frequency Syndrome, Urinary Incontinence, Urinary Incontinence, Urge
Usability Study of the FemPulse System
Recruiting
The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Instructions for Use (IFU), as applicable.
Gender:
FEMALE
Ages:
21 years and above
Trial Updated:
02/11/2025
Locations: Holy Cross Women's Hospital, Fort Lauderdale, Florida +1 locations
Conditions: Overactive Bladder
Reduced-dose Botox for Urgency Incontinence Among Elder Females
Recruiting
The purpose of this study is to study the treatment of urgency urinary incontinence (UUI), specifically among women 70 years and older, by comparing reduced versus standard dose of onabotulinumtoxinA (BTX; trade name BOTOX(c)) injection in the bladder.
Gender:
FEMALE
Ages:
70 years and above
Trial Updated:
02/06/2025
Locations: University of Alabama - Birmingham, Birmingham, Alabama +6 locations
Conditions: Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Recruiting
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
02/03/2025
Locations: Loma Linda University Health, Loma Linda, California
Conditions: Radiation Exposure, Overactive Bladder, Urge Incontinence, Urgency-frequency Syndrome
Percutaneous Nerve Evaluation Trial Time
Recruiting
Sacral neuromodulation (SNM) was approved by the Food and Drug Administration (FDA) for the treatment of urgency incontinence (UUI) in 1998. One of two trial phase techniques are utilized prior to placement of the implantable pulse generator (IPG) to predict a patient's success with the device: a percutaneous nerve evaluation (PNE) or a stage implantation. Patients who experience a \> 50% improvement in UUI symptoms progress to permanent implantation. PNE offers significant advantages compared t... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
01/24/2025
Locations: University of Chicago, Chicago, Illinois
Conditions: Urge Incontinence, Urgency-frequency Syndrome, Overactive Bladder
1 - 12 of 24